The Valley Desk

NCT04344795 · Interventional trial

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

Overall registry status Completed

Phase 1

Conditions Colorectal Cancer, Endometrial Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Non Small Cell Lung Cancer, Solid Tumor, Solid Tumors With PIK3Ca Mutation, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov